265 related articles for article (PubMed ID: 25114627)
1. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.
Hügle B; Hinze C; Lainka E; Fischer N; Haas JP
Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627
[TBL] [Abstract][Full Text] [Related]
2. Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who discontinued treatment.
Iglesias E; Torrente-Segarra V; Bou R; Ricart S; González MI; Sánchez J; Calzada J; Antón J
Rheumatol Int; 2014 Aug; 34(8):1053-7. PubMed ID: 24162563
[TBL] [Abstract][Full Text] [Related]
3. Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.
Glerup M; Herlin T; Twilt M
Clin Rheumatol; 2017 Mar; 36(3):671-676. PubMed ID: 28097448
[TBL] [Abstract][Full Text] [Related]
4. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
Guzman J; Oen K; Huber AM; Watanabe Duffy K; Boire G; Shiff N; Berard RA; Levy DM; Stringer E; Scuccimarri R; Morishita K; Johnson N; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey SE; Bruns A; Roth J; Campillo S; Benseler S; Chédeville G; Schneider R; Tse SM; Bolaria R; Gross K; Feldman B; Feldman D; Cameron B; Jurencak R; Dorval J; LeBlanc C; St Cyr C; Gibbon M; Yeung RS; Duffy CM; Tucker LB;
Ann Rheum Dis; 2016 Jun; 75(6):1092-8. PubMed ID: 25985972
[TBL] [Abstract][Full Text] [Related]
5. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
Ravelli A; Felici E; Magni-Manzoni S; Pistorio A; Novarini C; Bozzola E; Viola S; Martini A
Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis.
Serra CR; Rodrigues SH; Silva NP; Sztajnbok FR; Andrade LE
Clin Exp Rheumatol; 1999; 17(3):375-80. PubMed ID: 10410276
[TBL] [Abstract][Full Text] [Related]
9. Uveitis Associated with Juvenile Idiopathic Arthritis, our Observations.
Cosickic A; Halilbasic M; Selimovic A; Avdagic H
Med Arch; 2017 Feb; 71(1):52-55. PubMed ID: 28428675
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
[TBL] [Abstract][Full Text] [Related]
11. Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany.
Heiligenhaus A; Klotsche J; Niewerth M; Horneff G; Ganser G; Haas JP; Minden K
Arthritis Res Ther; 2020 Apr; 22(1):81. PubMed ID: 32293540
[TBL] [Abstract][Full Text] [Related]
12. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).
Berntson L; Nordal E; Fasth A; Aalto K; Herlin T; Nielsen S; Rygg M; Zak M; Rönnelid J;
Pediatr Rheumatol Online J; 2014; 12():22. PubMed ID: 24944545
[TBL] [Abstract][Full Text] [Related]
13. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.
Fitzpatrick L; Broadaway KA; Ponder L; Angeles-Han ST; Jenkins K; Rouster-Stevens K; Pelajo CF; Conneely K; Epstein MP; Lopez-Benitez J; Vogler LB; Prahalad S;
J Rheumatol; 2016 Apr; 43(4):799-803. PubMed ID: 26879356
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis.
Reyhan I; Zhukov OS; Lagier RJ; Bridgforth RF; Williams GJ; Popov JM; Naides SJ; Reiff A
Pediatr Rheumatol Online J; 2021 Feb; 19(1):14. PubMed ID: 33593401
[TBL] [Abstract][Full Text] [Related]
16. Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry.
Lainka E; Baehr M; Raszka B; Haas JP; Hügle B; Fischer N; Foell D; Hinze C; Weissbarth-Riedel E; Kallinich T; Horneff G; Windschall D; Lilienthal E; Niehues T; Neudorf U; Berendes R; Küster RM; Oommen PT; Rietschel C; Lutz T; Weller-Heinemann F; Tenbrock K; Heubner GL; Klotsche J; Wittkowski H
Pediatr Rheumatol Online J; 2021 Mar; 19(1):38. PubMed ID: 33752669
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibody-positive cohort constitutes homogeneous entity in juvenile idiopathic arthritis.
Ma X; Xin L; Sun J; Liu Z
Mod Rheumatol; 2016; 26(1):75-9. PubMed ID: 26025435
[TBL] [Abstract][Full Text] [Related]
19. High mobility group box protein 1-A prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis.
Pullerits R; Schierbeck H; Uibo K; Liivamägi H; Tarraste S; Talvik T; Sundberg E; Pruunsild C
Semin Arthritis Rheum; 2017 Feb; 46(4):444-450. PubMed ID: 27756498
[TBL] [Abstract][Full Text] [Related]
20. Later-onset rheumatoid factor negative polyarticular juvenile idiopathic arthritis (JIA): a unique patient group?
Greenwald AG; Zakerzadeh A; Laxer RM; Schneider R; Cameron B; Feldman B; Spiegel L; Tse SM; Silverman ED
Clin Exp Rheumatol; 2013; 31(4):645-52. PubMed ID: 23622111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
